M&A Deal Summary

Telegraph Hill Partners Acquires Ambion

On May 1, 2003, venture capital firm Telegraph Hill Partners acquired life science company Ambion for 11M USD

Acquisition Highlights
  • This is Telegraph Hill Partners’ 2nd transaction in the Life Science sector.
  • This is Telegraph Hill Partners’ largest (disclosed) transaction.
  • This is Telegraph Hill Partners’ 2nd transaction in the United States.
  • This is Telegraph Hill Partners’ 1st transaction in California.
Investment Fate
  • Ambion was sold to a strategic buyer in 2006.

M&A Deal Summary
Date 2003-05-01
Target Ambion
Sector Life Science
Buyer(s) Telegraph Hill Partners
Deal Type Buyout (LBO, MBO, MBI)
Deal Value 11M USD

Target

Ambion

Foster City, California, United States
Ambion, Inc. is in the field of RNA-based life science research and molecular diagnostics with products for handling, preserving, isolating, detecting and measuring RNA.

Search 199,713 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Telegraph Hill Partners

San Francisco, California, United States

Investor Investor Investor Investor Investor

Category Venture Capital Firm
Founded 2001
Size Middle-Market
Type Sector Focused
DESCRIPTION

Telegraph Hill Partners is a specialist private equity firm focused on investing in later-stage life science, medical device, and healthcare companies. Prospective companies should be at or near profitability and demonstrate success. Other areas of interest within the healthcare sector include life science technologies, chemistry/reagent suppliers, and information management. Telegraph Hill Partners was formed in 2001 and is based in San Francisco, California.

DEAL STATS #
Overall 2 of 33
Sector (Life Science) 2 of 12
Type (Buyout (LBO, MBO, MBI)) 1 of 7
State (California) 1 of 16
Country (United States) 2 of 30
Year (2003) 1 of 2
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2002-09-02 Dharmacon

Lafayette, United States

Dharmacon, Inc. is a supplier of innovative RNA and RNA-interference research (RNAi) products.

Buy $6M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2003-12-04 Aurora Discovery

Carlsbad,, California, United States

Aurora Discovery develops and markets premium quality high-density microplates used in high-throughput screening, live cell imaging and other life science applications.

Buy -
Mergr

Product

Company

Legal